Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2015) 38 P31 | DOI: 10.1530/endoabs.38.P31

SFEBES2015 Poster Presentations Clinical biochemistry (24 abstracts)

Single-centre audit of the diagnostic performance of plasma metanephrines with seated sampling for the diagnosis of phaeochromocytoma/paraganglioma

Christopher Boot 1 , Barry Toole 1 , Sarah Johnson 2 , Stephen Ball 3, & Dermot Neely 1

1Blood Sciences, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; 2Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; 3The Medical School, University of Newcastle upon Tyne, Newcastle upon Tyne, UK; 4Department of Endocrinology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Introduction: Measurement of plasma metanephrines (PMETS) is widely regarded as one of the best screening tests for phaeochromocytoma/paraganglioma (P/PGL). Current Endocrine Society guidelines recommend that samples for PMETS are ideally collected in the supine position after 30 min rest and interpreted using supine reference ranges, in order to optimise the diagnostic performance of the test. Current practice in our centre is to collect samples for PMETS from seated patients.

Aim: To determine if seated sampling for PMETS provides acceptable diagnostic performance in our centre.

Methods: Clinical and laboratory data of 113 patients were reviewed, gathered over a 4-year period 2010–2014. All had undergone preoperative PMETS measurement (LC-MS/MS) and all had post-operative pathology confirmation or exclusion of P/PGL.

Results: Of the113 patients included in the study, 40 had a histological diagnosis of P/PGL. Of these 40, three were considered pre and peri-operatively to be non-secretory. The remaining 73 patients had an alternative adrenal pathology. The diagnostic sensitivity of PMETS (either normetanephrine or metanephrine) above the upper limit of our in-house seated reference range was 93%. However, excluding three cases of PGL determined clinically and biochemically to be non-secretory raised the sensitivity to 100%. Diagnostic specificity was 91%. Applying published supine reference ranges made no difference to diagnostic sensitivity in this group of patients, but decreased diagnostic specificity to 77%.

Conclusions: While these data are derived from a relatively small study population, they demonstrate acceptable diagnostic performance for seated PMETS as a screening test for P/PGL. The data highlight a high diagnostic sensitivity for PMETS with seated sampling in our centre.

Volume 38

Society for Endocrinology BES 2015

Edinburgh, UK
02 Nov 2015 - 04 Nov 2015

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.